Rosalind

What Rosalind does

Rosalind (formerly OnRamp BioInformatics, rebranded March 2021 in honor of scientist Rosalind Franklin) is a privately held, San Diego-based SaaS company founded in 2013 by Tim Wesselman that operates a cloud-native bioinformatics discovery platform on Google Cloud Platform. The platform enables life-science researchers without programming or bioinformatics expertise to perform end-to-end genomic analyses across bulk RNA-seq, single-cell RNA-seq, NanoString nCounter and GeoMx spatial transcriptomics, small RNA-seq, ChIP-seq, and ATAC-seq, with integrated quality control, contamination detection, pathway interpretation across 50+ biomedical knowledge bases, and machine-learning-powered meta-analysis combining up to 50 multi-omics datasets. Supporting modules include the ROSALIND DxM COVID-19 variant monitoring system (developed with NIH RADx funding), real-time Collaboration Spaces with audit trails, and the ROSALIND Academy training platform.

The company generates revenue through annual subscription tiers — Enterprise, Professional/Academic, and Service Provider/CRO licenses — supplemented by a 14-day free trial funnel. Distribution is hybrid: self-serve product-led growth via the website captures SMB and individual researchers, an enterprise field-sales motion targets pharma, biotech, and large academic institutions with API integrations and SSO, and a Service Provider Network of vetted CROs and academic core facilities (e.g., Canopy Biosciences, Griffith University, UAB Medicine, Genetika Science) extends reach into translational and regenerative medicine workflows across 60+ countries. Strategic partnerships with NanoString (preferred nCounter analysis layer), Bruker Spatial Biology, CS Genetics, Rebus, Active Motif, Lexogen, and Advaita anchor the platform's instrument-adjacent positioning and channel reach.

The business is founder-led and appears to be lightly capitalized, with disclosed funding limited to small angel rounds from Pasadena Angels, TCA Venture Group, and East Los Capital. A March 2026 reference to a non-binding proposed transaction with Made in USA Inc. suggests a potential restructuring event, though no revenue, ARR, or valuation figures are publicly disclosed. The customer base spans pharma/biotech enterprises, academic medical centers, government public-health agencies, and CROs, served by 51-100 employees.

Name

Rosalind

Legal name

ROSALIND, Inc.

Website

https://rosalind.bio

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

51–100 employees

Short description

Rosalind is a San Diego-based cloud SaaS bioinformatics platform that enables life-science researchers without coding expertise to perform genomic analyses — including RNA-seq, single-cell, spatial transcriptomics, and ChIP-seq — serving pharma, biotech, academic, and public-health customers across 60+ countries via subscription tiers and a service-provider channel network.

Ownership category

akta.pro rank

Product category

Bioinformatics Software

NAICS

Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (5182), Computer Systems Design and Related Services (54151)

SIC

Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)

akta.pro secondary industries

Knowledge Management & Scientific Collaboration / Literature Intelligence (HLAGAJAN), Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D) (HLAGAJAF)

Keywords

• Cloud bioinformatics platform
• NGS data analysis
• Single cell RNA-seq
• Spatial transcriptomics analysis
• Multi-omics interpretation

Headquarters

HQ city

San Diego

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

1. SaaS Subscription - Enterprise: Enterprise subscriptions with full platform access, advanced features, API integration, SSO support, and dedicated collaboration spaces for large organizations.
2. SaaS Subscription - Professional/Academic: Tiered professional and academic subscriptions with different feature levels for individual researchers and smaller institutions.
3. Service Provider/CRO Licenses: Specialized licenses for contract research organizations, service providers, and academic core facilities to serve end clients using ROSALIND.
4. Freemium/Trial: 14-day free trial enabling scientists to experience platform capabilities before subscription commitment.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

Rosalind provides a cloud-native, no-code bioinformatics SaaS platform that enables life science researchers to perform next-generation sequencing (NGS) data analysis without programming. The platform supports Bulk RNA-seq, Single Cell RNA-seq, NanoString nCounter, GeoMx Spatial Transcriptomics, ChIP-seq, ATAC-seq, and Small RNA-seq, with integrated interpretation via a 50+ knowledge-base Knowledge Graph and ML-powered Meta-Analysis. It is sold via Enterprise, Professional/Academic, and Service Provider/CRO subscriptions.

Product overview

ROSALIND is a cloud-based discovery platform and data hub for scientists providing do-it-yourself bioinformatics analysis without coding. The platform operates as a unified platform-plus-modules architecture centered on the core ROSALIND Platform, which provides end-to-end NGS data analysis through interconnected analysis modules including Bulk RNA-seq, Single Cell Gene Expression, NanoString nCounter Analysis (including GeoMx Spatial Transcriptomics), Small RNA-seq, ChIP-seq, and ATAC-seq Analysis. Supporting services include the Knowledge Hub for documentation, ROSALIND Academy for training, Service Provider Network for outsourcing, and ROSALIND Spaces for collaboration. The platform also includes specialized modules for COVID-19 monitoring (DxM) and advanced Meta-Analysis across multi-omics datasets. Built on Google Cloud Platform with emphasis on security, the platform serves pharma, biotech, and academic researchers across 60+ countries.

Differentiator

Problem solved

Functional benefit

Products and services

• ROSALIND Platform Cloud-based discovery platform and data hub providing do-it-yourself bioinformatics analysis without coding for life science researchers. Supports RNA-seq, NanoString, single cell, ChIP-seq, ATAC-seq, and GeoMx spatial transcriptomics with interactive visualization, collaboration tools, and pathway interpretation.
• Bulk RNA-seq Analysis Gene expression analysis module for bulk RNA-seq data with quality control, differential expression analysis, pathway interpretation, and publication-ready visualizations.
• Single Cell Gene Expression Analysis End-to-end web-based single cell RNA-seq analysis optimized for 10X Genomics Chromium with automated clustering (Seurat/K-Means), assisted cell type identification, and interactive T-SNE/UMAP visualization.
• NanoString nCounter Analysis Analysis solution for NanoString nCounter Gene Expression and miRNA Expression data providing quality control, normalization, and advanced visualization, positioned as Bruker's recommended and preferred solution.
• GeoMx Spatial Transcriptomics Analysis Spatial transcriptomics analysis for NanoString GeoMx Whole Transcriptome Analysis data with quality control, AOI and gene filtering, multiple normalization methods, and spatial differential expression.
• Small RNA-seq Analysis Data analysis for small RNA-seq experiments supporting gene regulation and anti-sense research with comprehensive quality control and pathway interpretation.
• ChIP-seq Analysis Comprehensive ChIP-seq data analysis for histone mark and transcription factor studies with dynamic track plots and collaboration capabilities optimized for Active Motif kits.
• ATAC-seq Analysis Genome-wide chromatin accessibility analysis for ATAC-seq experiments enabling visualization and interpretation of chromatin states.
• ROSALIND DxM COVID-19 Monitoring System COVID-19 diagnostic monitoring system for SARS-CoV-2 viral mutation tracking and diagnostic test performance monitoring, supporting antigen, PCR, LAMP, FISH, and CRISPR assays with severity scoring.
• Service Provider Network (CRO/Distributor Licensing) Authorized network connecting scientists with vetted contract research organizations, academic core facilities, and distributors trained in ROSALIND for integrated end-to-end genomics services.

Quantifiable outcome

• Same day results for RNA-seq and other NGS analysis workflows
• +2 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability6 records

Feature7 records

Partnerships

Twelve partnerships are on record, tiered flagship, core and minor.

• CS GeneticsflagshipStrategic or Co-development Partner · 19 September 2024Strategic partnership to democratize single-cell genomics by combining CS Genetics' SimpleCell instrument-free technology with ROSALIND's comprehensive multi-omics analysis platform. Aims to reduce cost and complexity of single-cell research for biopharma and academic teams.
• Rebus (Esper system)coreTechnology or Integration · 8 June 2022Codevelopment of spatial omics analysis software for Rebus Esper system to democratize single-cell spatial analysis and increase biological understanding.
• HELiXrUS and GeninusminorChannel Partner/ Reseller/ Distributor · 15 April 2021Partnerships bringing new Single Cell Analysis Services to cancer researchers with web-based biological analysis and interpretation of single cell clusters.
• Canopy Biosciences (Bruker Spatial Biology)coreChannel Partner/ Reseller/ Distributor · 17 June 2020Partnership offering ROSALIND interactive data analysis platform for Canopy's gene expression services including NanoString nCounter and RNA Seq for clinical and research customers.
• LexogencoreTechnology or Integration · 17 June 2020Availability of QuantSeq 3' mRNA-Seq data analysis pipeline on ROSALIND with visual exploration and pathway interpretation across 50+ knowledge bases.
• NanoString TechnologiesflagshipTechnology or Integration · 20 May 2020Development partnership for cloud-based nCounter data analysis solutions built into ROSALIND platform. Expanded to support COVID-19 research through early access program with nCounter COVID Panel Plus.
• Active MotifcoreTechnology or Integration · 12 December 2018Partnership providing optimized ChIP-seq data analysis experience with dynamic track plots and advanced collaboration capabilities tailored for Active Motif kits and antibodies.
• Advaita BioInformaticscoreStrategic or Co-development Partner · 3 May 2018Strategic partnership to provide comprehensive research experience from sample to interpretation with seamless handoff between systems for genomic data analysis.
• Griffith University Central Facility for GenomicscoreChannel Partner/ Reseller/ DistributorAcademic core facility providing NanoString nCounter and GeoMx spatial transcriptomics services using ROSALIND platform for Queensland, Australia researchers.
• UAB Medicine NanoString LaboratorycoreChannel Partner/ Reseller/ DistributorAcademic medical center core providing NanoString nCounter multiplex gene expression profiling services using ROSALIND for biomarker discovery and translational research.
• InVivo BiosystemsminorChannel Partner/ Reseller/ DistributorTranslational research organization offering RNA-seq-based genetic signature studies using ROSALIND for mechanism-of-action discovery and biomarker identification.
• Genetika ScienceminorChannel Partner/ Reseller/ DistributorLife science distributor and molecular services provider in Indonesia offering NanoString nCounter gene expression profiling using ROSALIND for biomedical research.

Scale indicators3 records

Recent moves1 record

Expansion highlights6 records

Broad incumbents

• Benchling: Benchling is a cloud-based R&D platform spanning lab notebooks, molecular biology, and registry workflows. While more focused on wet-lab informatics, it competes for the same translational and biopharma R&D platform budget and offers adjacent capabilities Rosalind lacks.
• Dotmatics: Dotmatics offers a scientific R&D informatics platform spanning biology, chemistry, and lab data management. Its broader scope overlaps with Rosalind's data-management and collaboration thesis and it increasingly competes for pharma R&D informatics budgets.
• Illumina BaseSpace: Illumina BaseSpace is the cloud informatics environment tied to the world's leading NGS instrument franchise. While broader than Rosalind, it competes directly on NGS analysis workflows and benefits from being bundled with the dominant sequencer installed base.

Direct peers

• Velsera (formerly Seven Bridges Genomics): Velsera operates a cloud genomics and multimodal data analysis platform serving pharma, biotech, and research consortia. It is a direct cloud bioinformatics peer with overlapping RNA-seq, multi-omics, and translational research use cases.
• DNAnexus: DNAnexus provides a cloud-based genomics and biomedical data analysis platform serving pharma, biotech, and academic researchers. It is the most direct competitor to Rosalind's cloud-native, multi-omics SaaS model with enterprise pharma positioning.
• Partek: Partek provides genomics and multi-omics analysis software (Flow, Partek Pathways) widely used in academic and translational research. It is a direct competitor for bulk RNA-seq, single cell, and pathway interpretation workflows.
• Genedata: Genedata provides enterprise scientific data analytics and workflow software for biopharma R&D, including omics and high-throughput biology. It targets the same translational and pharma research customer base as Rosalind with a deeper biopharma enterprise footprint.
• QIAGEN Digital Insights (CLC bio): QIAGEN Digital Insights offers CLC bio and other bioinformatics software for NGS analysis, including RNA-seq, variant calling, and genomic interpretation. It competes head-to-head with Rosalind across bulk RNA-seq and clinical/translational bioinformatics workflows.
• Geneious (Biomatters): Geneious provides desktop and cloud bioinformatics software for DNA/RNA analysis used widely in academic and applied research. It competes on analysis ease-of-use across similar assay types but lacks Rosalind's cloud-native multi-tenant SaaS architecture.

Emerging players

• BioRender: BioRender is a scientific visualization and figure-making platform with strong adoption among life science researchers. While not a direct analysis competitor, it shares Rosalind's scientist-first, no-code product ethos and is increasingly expanding into broader research workflow tools.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/rosalind_bio
• Facebookfacebook.com/onrampbioinformatics
• LinkedInlinkedin.com/company/rosalindbio

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rosalind